Smoking Risk Effects¶
Risk Overview¶
Todo
Provide a brief description of the risk, including potential opportunities for confounding (factors that may cause or be associated with the risk exposure), effect modification/generalizability, etc. by any relevant variables. Note that literature reviews and speaking with the GBD risk modeler will be good resources for this.
GBD 2017 Modeling Strategy¶
[GBD-2017-Risk-Factors-Appendix-Smoking-Effects]
Note
This section will describe the GBD modeling strategy for risk effects. For a description of GBD modeling strategy for risk exposure, see the risk exposure page.
The smoking risk factor affects several outcomes in GBD, including tuberculosis, lower respiratory tract infections, oesophageal cancer, stomach cancer, bladder cancer, liver cancer, laryngeal cancer, lung cancer, breast cancer, cervical cancer, colorectal cancer, lip and oral cancer, nasopharyngeal cancer, other pharyngeal cancer, pancreatic cancer, kidney cancer, leukaemia, ischaemic heart disease, ischaemic stroke, haemorrhagic stroke, subarachnoid haemorrhage, atrial fibrillation and flutter, aortic aneurysm, peripheral arterial disease, chronic obstructive pulmonary disease, other chronic respiratory diseases, asthma, peptic ulcer disease, gallbladder and biliary tract diseases, Alzheimer disease and other dementias, Parkinson disease (protective), multiple sclerosis, type‐II diabetes, rheumatoid arthritis, low back pain, cataracts, macular degeneration, and fracture.
Notably, the relative risks for the smoking risk factor in GBD are defined separately for current smokers (intensity of smoking) and former smokers (time since quitting). The TMREL for the smoking risk factor is never smokers.
The relative risks for the smoking risk factor cannot be pulled using standard tools. Rather, filepaths to the relative risk data (both for current and former smokers) are available in this excel document
.
The relative risk data for the smoking risk factor are defined as a continous risk curve. This curve is modeled according to “mesh points” that are documented in the above excel file and the risk curve is assumed to connect linearly between each mesh point.
Outcome |
Outcome type |
Outcome ID |
Affected measure |
Note |
---|---|---|---|---|
Tuberculosis |
Cause |
297 |
||
Lower respiratory tract infections |
Cause |
322 |
||
Oesophageal cancer |
Cause |
411 |
||
Stomach cancer |
Cause |
414 |
||
Bladder cancer |
Cause |
474 |
||
Liver cancer |
Cause |
417 |
Not most detailed cause |
|
Laryngeal cancer |
Cause |
423 |
||
Lung cancer |
Cause |
426 |
||
Breast cancer |
Cause |
429 |
||
Cervical cancer |
Cause |
432 |
Female only cause |
|
Colorectal cancer |
Cause |
441 |
||
Lip and oral cancer |
Cause |
444 |
||
Nasopharyngeal cancer |
Cause |
447 |
||
Other pharyngeal cancer |
Cause |
450 |
||
Pancreatic cancer |
Cause |
456 |
||
Kidney cancer |
Cause |
471 |
||
Leukaemia |
Cause |
487 |
Not most detailed cause |
|
Ischaemic heart disease |
Cause |
493 |
||
Ischaemic stroke |
Cause |
495 |
||
Haemorrhagic stroke (Intracerebral hemorrhage) |
Cause |
496 |
||
Subarachnoid haemorrhage |
Cause |
497 |
||
Atrial fibrillation and flutter |
Cause |
500 |
||
Aortic aneurysm |
Cause |
501 |
||
Peripheral arterial disease |
Cause |
502 |
||
Chronic obstructive pulmonary disease |
Cause |
509 |
||
Other chronic respiratory diseases |
Cause |
520 |
||
Asthma |
Cause |
515 |
||
Peptic ulcer disease |
Cause |
527 |
||
Gallbladder and biliary tract diseases |
Cause |
534 |
||
Alzheimer disease and other dementias |
Cause |
543 |
||
Parkinson disease |
Cause |
544 |
Smoking exposure is protective for this cause |
|
Multiple sclerosis |
Cause |
546 |
||
Type‐II diabetes |
Cause |
976 |
||
Rheumatoid arthritis |
Cause |
627 |
||
Low back pain |
Cause |
630 |
YLD only cause |
|
Cataracts |
Cause |
671 |
YLD only cause |
|
Macular degeneration |
Cause |
672 |
YLD only cause |
|
Fracture |
Cause |
YLD only cause |
Vivarium Modeling Strategy¶
Note
This section will describe the Vivarium modeling strategy for risk effects. For a description of Vivarium modeling strategy for risk exposure, see the risk exposure page.
Outcome |
Outcome type |
Outcome ID |
Affected measure |
Note |
---|---|---|---|---|
Lung cancer |
Cause |
426 |
Incidence |
|
Ischemic heart disease |
493 |
Cause-specific mortality rate |
For the smoking related mortality model |
|
Chronic obstructive pulmonary disease |
509 |
Cause-specific mortality rate |
For the smoking related mortality model |
Lung Cancer Incidence¶
See the relevant documentation for the lung cancer cause model and the forecasted smoking risk exposure model.
Incidence Relative Risk Data¶
The lung cancer relative risks cannot be pulled using get_draws or other standard tools.
The mesh points for the relative risk curves for current smokers can be found here: /home/j/WORK/05_risk/risks/TEAM/sub_risks/tobacco/raw_data/metadata/rr/systematic_review_extraction_sheets/draws_for_PAF/426_lung_cancer/draws_pack.csv
The mesh points for the relative risk curves for former smokers can be found here: /home/j/WORK/05_risk/risks/TEAM/sub_risks/tobacco/raw_data/metadata/rr/systematic_review_extraction_sheets/draws_for_PAF/426_lung_cancer/draws_quit.csv
The following code demonstrates how to assign relative risk values to individual simulants based on their exposure values.
from scipy.interpolate import interp1d
"""
rr_i =: simulant's individual relative risk
smoking_status_i =: simulant's smoking status exposure
draw_x =: selected draw for a given model run
sex_i =: simulant's sex
age_group_i =: simulant's age group
pack_year_exposure_i =: simulant's pack year exposure value, if applicable
years_since_quitting_exposure_i =: simulant's years since quitting exposure value, if applicable
"""
if smoking_status_i.isin(['never','unassigned]):
rr_i = 1
elif smoking_status_i == 'current':
rr_current = pd.read_csv('/home/j/WORK/05_risk/risks/TEAM/sub_risks/tobacco/raw_data/metadata/rr/systematic_review_extraction_sheets/draws_for_PAF/426_lung_cancer/draws_pack.csv')
rr_current_i = rr_current.loc[rr_current.draw=draw_X].loc[rr_current.sex_id==sex_i].loc[rr_current.age_group_id==age_group_i]
x = rr_current_i.exposure.values
y = rr_current_i.rr.values
current_rr_function_i = interp1d(x, y)
rr_i = current_rr_function_i(pack_year_exposure_i)
elif smoking_status_i == 'former':
rr_former = pd.read_csv('/home/j/WORK/05_risk/risks/TEAM/sub_risks/tobacco/raw_data/metadata/rr/systematic_review_extraction_sheets/draws_for_PAF/426_lung_cancer/draws_quit.csv')
rr_former_i = rr_former.loc[rr_former.draw=draw_X].loc[rr_former.sex_id==sex_i].loc[rr_former.age_group_id==age_group_i]
x = rr_former_i.exposure.values
y = rr_former_i.rr.values
former_rr_function_i = interp1d(x, y)
rr_i = former_rr_function_i(years_since_quitting_exposure_i)
Incidence PAF Calculation¶
The lung cancer PAF specific to an age, sex, location, and year demographic group for smoking should be calculated according to the following equation:
Where, \(\overline{rr_\text{a,s,l,y}}\) is the mean value of relative risks for all simulants in a given age, sex, location, and year demographic group.
Application of Risk Factor¶
The smoking risk factor should affect the incidence rates of the preclinical and indolent lung cancer cause model states, \(incidence_\text{PC}\) and \(incidence_I\), respectively, using the same relative risk values such that:
And,
Where,
Parameter |
Definition |
Note |
---|---|---|
\(incidence_\text{PC_i}\) |
Individual simulant’s preclinical lung cancer incidence probability |
|
\(incidence_\text{PC}\) |
Population level incidence rate of preclinical lung cancer |
As defined in the lung cancer cause model document |
\(incidence_\text{I_i}\) |
Individual simulant’s incidence lung cancer incidence probability |
|
\(incidence_\text{I}\) |
Population level incidence rate of indolent lung cancer |
As defined in the lung cancer cause model document |
\(PAF_\text{a,s,l,y}\) |
Lung cancer PAF for smoking for simulant’s demographic group |
As calculated in the Incidence PAF Calculation section |
\(rr_i\) |
Individual simulant’s relative risk value |
Assigned as described in the Incidence Relative Risk Data section |
Validation and Verification Criteria¶
While validating the exact application of the relative risks will be difficult to do with Vivarium simulation outputs, results should be stratified by smoking status and then, the incidence rates for lung cancer should be lowest for never smokers, higher for former smokers, and highest for current smokers.
Assumptions and Limitations¶
This model is limited in that it relies on the GBD relative risk structure that does not differentiate relative risks of former smokers by pack-year history so that current smokers with low pack-year histories who become former smokers may increase their risk of lung cancer by doing so, according to the GBD relative risk curves.
This model is limited in that it assumes the relative risk for smoking and lung cancer applies to preclinical and indolent lung cancer incidence rates equally. However, there is data that suggests that while indolent lung cancers occur at higher rates among smokers than nonsmokers, lung cancers are more likely to be indolent among non-smokers than among smokers, as tumor growth rates tend to be higher in smokers than never smokers [Mackintosh-et-al-2014].
As described in the forecasted smoking risk exposure model, some age groups will have unassigned smoking status exposures which we are assuming have a relative risk value of one. For groups with unassigned smoking status exposures, the smoking risk factor will not have an affect on lung cancer incidence.
Bias in the Population Attributable Fraction¶
As noted in the Population Attributable Fraction section of the Modeling Risk Factors document, using a relative risk adjusted for confounding to compute a population attributable fraction at the population level will introduce bias.
Todo
Outline the potential direction and magnitude of the potential PAF bias in GBD based on what is understood about the relationship of confounding between the risk and outcome pair using the framework discussed in the Population Attributable Fraction section of the Modeling Risk Factors document.
References¶
- Mackintosh-et-al-2014
Mackintosh JA, Marshall HM, Yang IA, Bowman RV, Fong KM. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer. Respirology. 2014 Jul;19(5):755-62. doi: 10.1111/resp.12311. Epub 2014 May 6. PMID: 24797504. Available here.
Todo
Update the GBD 2017 Risk Factor Methods appendix citation to be unique to your risk effects page (replace ‘Risk-Effects-Model-Template’ with ‘{Risk Name}-Effects’)
Update the appropriate page numbers in the GBD risk factors methods appendix below
Add additional references as necessary
- GBD-2017-Risk-Factors-Appendix-Smoking-Effects
Pages ???-??? in Supplementary appendix 1 to the GBD 2017 Risk Factors Capstone:
(GBD 2017 Risk Factors Capstone) GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1923-1994. DOI: https://doi.org/10.1016/S0140-6736(18)32225-6